Recent manuscripts
Archive
Editorial Board
Aims and Scope
Open Access
Indexing
Contact us
Authorship & COI
Principles of Transparency Checklist
Publication Ethics
Crossmark
Data Policies
Supporting Diversity
Instructions to authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Special Publications & Reprints
Preprints
RESEARCH PAPER
Effects of smoking cessation on serum leptin and adiponectin levels
1
6th Respiratory Medicine Department, Sotiria General Hospital for Thoracic Diseases, Athens, Greece
2
Respiratory Medicine Department, University of Thessaly School of Medicine, University Hospital of Larissa, Larissa, Greece
Submission date: 2015-02-13
Acceptance date: 2015-08-20
Publication date: 2015-09-03
Corresponding author
Maria Kryfti
6th Respiratory Medicine Department, Sotiria General Hospital for Thoracic Diseases, Mesogeion 152, 11527 Athens, Greece
6th Respiratory Medicine Department, Sotiria General Hospital for Thoracic Diseases, Mesogeion 152, 11527 Athens, Greece
Tobacco Induced Diseases 2015;13(September):30
KEYWORDS
ABSTRACT
Background:
Evidence on the association of leptin and adiponectin and smoking is limited and discordant. Leptin and adiponectin represent the most abundant adipokines in human plasma that play crucial roles in the pathophysiology of metabolic syndrome, atherosclerosis and insulin resistance. Leptin up-regulates the expression of several pro-inflammatory cytokines and is increased upon weight gain. Adiponectin has been shown to possess insulin sensitizing, anti -inflammatory and anti-atherogenic properties and is increased upon weight reduction. Our aim was to assess the effects of smoking cessation on serum leptin and adiponectin levels.
Methods:
We assessed the changes in serum leptin and adiponectin levels, serum CRP levels and BMI in apparently healthy smokers after 3 and 6 months of abstinence from smoking. Successful cessation was confirmed by an exhaled carbon monoxide measurement. 26 healthy non-smokers were recruited as controls.
Results:
Among the sample group, 32 subjects had quitted smoking at 3 months and 29 subjects at 6 months. Samples’ leptin increased significantly from baseline to three months (mean change 3.76 ng/ml [95 % CI 0.89, 6.64], p =0.012) and then decreased significantly from three to six months of smoking cessation (mean change -4,29 ng/ml [95 % CI −7.34, −6.64], p = 0.008). Samples’ adiponectin increased significantly from baseline to three months of abstinence from smoking (mean change 2.34 [95 % CI −0.05, 4.73], p −0.05). BMI was significantly increased (mean change 2.03 kg/m2 [95 % CI 1.60, 2.46], p <0.05), while CRP decreased significantly from baseline to 6 months of smoking cessation (mean change −0.68 mg/dl [95 % CI −1.06, −0.30], p = 0.001).
Conclusions:
Smoking quitters’ leptin levels appear to increase 3 months after smoking cessation and then decrease from 3 to 6 months of abstinence from smoking. Adiponectin levels increase during the first trimester of smoking cessation. The decrease in CRP levels indicates that the low grade inflammation observed in smokers is gradually restored. The alterations of serum leptin and adiponectin after 6 months of smoking cessation suggest the same but do not reach statistically significant levels. Weight gain and changes in fat distribution may attenuate the beneficial effects of smoking cessation.
Evidence on the association of leptin and adiponectin and smoking is limited and discordant. Leptin and adiponectin represent the most abundant adipokines in human plasma that play crucial roles in the pathophysiology of metabolic syndrome, atherosclerosis and insulin resistance. Leptin up-regulates the expression of several pro-inflammatory cytokines and is increased upon weight gain. Adiponectin has been shown to possess insulin sensitizing, anti -inflammatory and anti-atherogenic properties and is increased upon weight reduction. Our aim was to assess the effects of smoking cessation on serum leptin and adiponectin levels.
Methods:
We assessed the changes in serum leptin and adiponectin levels, serum CRP levels and BMI in apparently healthy smokers after 3 and 6 months of abstinence from smoking. Successful cessation was confirmed by an exhaled carbon monoxide measurement. 26 healthy non-smokers were recruited as controls.
Results:
Among the sample group, 32 subjects had quitted smoking at 3 months and 29 subjects at 6 months. Samples’ leptin increased significantly from baseline to three months (mean change 3.76 ng/ml [95 % CI 0.89, 6.64], p =0.012) and then decreased significantly from three to six months of smoking cessation (mean change -4,29 ng/ml [95 % CI −7.34, −6.64], p = 0.008). Samples’ adiponectin increased significantly from baseline to three months of abstinence from smoking (mean change 2.34 [95 % CI −0.05, 4.73], p −0.05). BMI was significantly increased (mean change 2.03 kg/m2 [95 % CI 1.60, 2.46], p <0.05), while CRP decreased significantly from baseline to 6 months of smoking cessation (mean change −0.68 mg/dl [95 % CI −1.06, −0.30], p = 0.001).
Conclusions:
Smoking quitters’ leptin levels appear to increase 3 months after smoking cessation and then decrease from 3 to 6 months of abstinence from smoking. Adiponectin levels increase during the first trimester of smoking cessation. The decrease in CRP levels indicates that the low grade inflammation observed in smokers is gradually restored. The alterations of serum leptin and adiponectin after 6 months of smoking cessation suggest the same but do not reach statistically significant levels. Weight gain and changes in fat distribution may attenuate the beneficial effects of smoking cessation.
REFERENCES (56)
1.
Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis. 2005;181(2):381–8.
2.
Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med. 2006;45(18):1039–43.
3.
Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health. 2005;43(2):295–301.
4.
Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008;201(2):225–35.
5.
Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339(8802):1128–30.
6.
Campisi R, Czernin J, Schoder H, Sayre JW, Marengo FD, Phelps ME, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation. 1998;98(2):119–25.
7.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32.
8.
Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50(9):1511–25.
9.
Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, et al. Transient increase in obese gene expression after food intake or insulin administration. Nature. 1995;377(6549):527–9.
10.
Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000;68(4):437–46.
11.
Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev. 2005;6(1):13–21.
12.
Beltowski J, Jamroz-Wisniewska A, Widomska S. Adiponectin and its role in cardiovascular diseases. Cardiovasc Hematol Disord Drug Targets. 2008;8(1):7–46.
13.
Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86(8):3815–9.
14.
Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2009;70(2):221–6.
15.
Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004;27(10):2450–7.
16.
Ble A, Windham BG, Bandinelli S, Taub DD, Volpato S, Bartali B, et al. Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study). Am J Cardiol. 2005;96(7):991–5.
17.
Eliasson B, Smith U. Leptin levels in smokers and long-term users of nicotine gum. Eur J Clin Invest. 1999;29(2):145–52.
18.
Perkins KA, Fonte C. Effects of smoking status and smoking cessation on leptin levels. Nicotine Tob Res. 2002;4(4):459–66.
19.
Nicklas BJ, Tomoyasu N, Muir J, Goldberg AP. Effects of cigarette smoking and its cessation on body weight and plasma leptin levels. Metabolism. 1999;48(6):804–8.
20.
Otsuka F, Kojima S, Maruyoshi H, Matsuzawa Y, Funahashi T, Kaikita K, et al. Smoking cessation is associated with increased plasma adiponectin levels in men. J Cardiol. 2009;53(2):219–25.
21.
Efstathiou SP, Skeva, II, Dimas C, Panagiotou A, Parisi K, Tzanoumis L, et al. Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Atherosclerosis. 2009;205(2):632–6.
22.
Gonseth S, Locatelli I, Bize R, Nussle S, Clair C, Pralong F, et al. Leptin and smoking cessation: secondary analyses of a randomized controlled trial assessing physical activity as an aid for smoking cessation. BMC Public Health. 2014;14:911.
23.
Ahima RS. Central actions of adipocyte hormones. Trends Endocrinol Metab. 2005;16(7):307–13.
24.
Takabatake N, Nakamura H, Minamihaba O, Inage M, Inoue S, Kagaya S, et al. A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am J Respir Crit Care Med. 2001;163(6):1314–9.
25.
La Cava A, Alviggi C, Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med (Berl). 2004;82(1):4–11.
26.
Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis. 2005;64(8):1195–8.
27.
Bruno A, Pace E, Chanez P, Gras D, Vachier I, Chiappara G, et al. Leptin and leptin receptor expression in asthma. J Allergy Clin Immunol. 2009;124(2):230-7, 237 e1-4.
28.
Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361(9353):226–8.
29.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.
30.
SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149–59.
31.
Bruno A, Alessi M, Soresi S, Bonanno A, Riccobono L, Montalbano AM, et al. Increased leptin/leptin receptor pathway affects systemic and airway inflammation in COPD former smokers. J Inflamm Res. 2011;4:51–9.
32.
Kotani K, Hazama A, Hagimoto A, Saika K, Shigeta M, Katanoda K, et al. Adiponectin and smoking status: a systematic review. J Atheroscler Thromb. 2012;19(9):787–94.
33.
Sztalryd C, Hamilton J, Horwitz BA, Johnson P, Kraemer FB. Alterations of lipolysis and lipoprotein lipase in chronically nicotine-treated rats. Am J Physiol. 1996;270(2 Pt 1):E215–23.
34.
Hellerstein MK, Benowitz NL, Neese RA, Schwartz JM, Hoh R, Jacob P, 3rd, et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest. 1994;93(1):265–72.
35.
Carney RM, Goldberg AP. Weight gain after cessation of cigarette smoking. A possible role for adipose-tissue lipoprotein lipase. N Engl J Med. 1984;310(10):614–6.
36.
Brunzell JD, Goldberg AP, Schwartz RS. Cigarettes smoking and adipose tissue lipoprotein lipase. Int J Obes. 1980;4(2):101–3.
37.
Pomerleau OF, Rosecrans J. Neuroregulatory effects of nicotine. Psychoneuroendocrinology. 1989;14(6):407–23.
38.
Miell JP, Englaro P, Blum WF. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res. 1996;28(12):704–7.
39.
Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289(14):1799–804.
40.
Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005;45(6):1094–100.
41.
Andersson K, Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int J Obes Relat Metab Disord. 2001;25(8):1225–32.
42.
Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32(2):47–50.
43.
Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health. 1987;77(4):439–44.
44.
Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med. 1991;324(11):739–45.
45.
Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA. 1989;261(8):1169–73.
46.
Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG. The effect of nicotine on energy expenditure during light physical activity. N Engl J Med. 1989;320(14):898–903.
47.
Hofstetter A, Schutz Y, Jequier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med. 1986;314(2):79–82.
48.
Klesges RC, Meyers AW, Klesges LM, La Vasque ME. Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull. 1989;106(2):204–30.
49.
Grunberg NE. Nicotine, cigarette smoking, and body weight. Br J Addict. 1985;80(4):369–77.
50.
Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131(5):1557–66.
51.
Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29–33.
52.
Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res. 2005;96(10):1042–52.
53.
Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006;64(4):355–65.
54.
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595–9.
55.
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–5.
56.
Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17(10):2167–76.
CITATIONS (24):
1.
Association of anthropometric indices with continuous metabolic syndrome in children and adolescents: the CASPIAN-V study
Hanieh-Sadat Ejtahed, Mostafa Qorbani, Mohammad Esmaeil Motlagh, Pooneh Angoorani, Shirin Hasani-Ranjbar, Hasan Ziaodini, Majzoubeh Taheri, Zeinab Ahadi, Shaghayegh Beshtar, Tahereh Aminaee, Ramin Heshmat, Roya Kelishadi
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
Hanieh-Sadat Ejtahed, Mostafa Qorbani, Mohammad Esmaeil Motlagh, Pooneh Angoorani, Shirin Hasani-Ranjbar, Hasan Ziaodini, Majzoubeh Taheri, Zeinab Ahadi, Shaghayegh Beshtar, Tahereh Aminaee, Ramin Heshmat, Roya Kelishadi
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
2.
Leptin, Orexin, Peptide YY, and Ghrelin Associated With Relapse During Smoking Cessation
José Ignacio de Granda-Orive, Ana María de Granda-Beltrán, Gonzalo Segrelles-Calvo
Archivos de Bronconeumología (English Edition)
José Ignacio de Granda-Orive, Ana María de Granda-Beltrán, Gonzalo Segrelles-Calvo
Archivos de Bronconeumología (English Edition)
3.
Exposure to cigarette smoke disturbs adipokines secretion causing intercellular damage and insulin resistance in high fructose diet-induced metabolic disorder mice
Sanghwa Kim, Ah Young Lee, Hyeon-Jeong Kim, Seong-Ho Hong, Ryeo-Eun Go, Kyung-Chul Choi, Kyung-Sun Kang, Myung-Haing Cho
Biochemical and Biophysical Research Communications
Sanghwa Kim, Ah Young Lee, Hyeon-Jeong Kim, Seong-Ho Hong, Ryeo-Eun Go, Kyung-Chul Choi, Kyung-Sun Kang, Myung-Haing Cho
Biochemical and Biophysical Research Communications
4.
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products
Michael John Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke, Rolf Weitkunat
Biomarkers
Michael John Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke, Rolf Weitkunat
Biomarkers
5.
Age and cigarette smoking modulate the relationship between pulmonary function and arterial stiffness in heart failure patients
Li Li, Bangchuan Hu, Shijin Gong, Yihua Yu, Jing Yan
Medicine
Li Li, Bangchuan Hu, Shijin Gong, Yihua Yu, Jing Yan
Medicine
6.
Relación de la leptina, la orexina, el péptido YY y el ghrelin con la recaída al dejar de fumar
José Ignacio de Granda-Orive, Ana María de Granda-Beltrán, Gonzalo Segrelles-Calvo
Archivos de Bronconeumología
José Ignacio de Granda-Orive, Ana María de Granda-Beltrán, Gonzalo Segrelles-Calvo
Archivos de Bronconeumología
7.
Adiponectin circulating levels and 10-year (2002–2012) cardiovascular disease incidence: the ATTICA Study
Ioannis Kyrou, Olga Tsantarlioti, Demosthenes B. Panagiotakos, Constantine Tsigos, Ekavi Georgousopoulou, Christina Chrysohoou, Ioannis Skoumas, Dimitrios Tousoulis, Christodoulos Stefanadis, Christos Pitsavos
Endocrine
Ioannis Kyrou, Olga Tsantarlioti, Demosthenes B. Panagiotakos, Constantine Tsigos, Ekavi Georgousopoulou, Christina Chrysohoou, Ioannis Skoumas, Dimitrios Tousoulis, Christodoulos Stefanadis, Christos Pitsavos
Endocrine
8.
Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation
Maki Komiyama, Hiromichi Wada, Hajime Yamakage, Noriko Satoh-Asahara, Yoichi Sunagawa, Tatsuya Morimoto, Yuka Ozaki, Akira Shimatsu, Yuko Takahashi, Koji Hasegawa, Tatsuo Shimosawa
PLOS ONE
Maki Komiyama, Hiromichi Wada, Hajime Yamakage, Noriko Satoh-Asahara, Yoichi Sunagawa, Tatsuya Morimoto, Yuka Ozaki, Akira Shimatsu, Yuko Takahashi, Koji Hasegawa, Tatsuo Shimosawa
PLOS ONE
9.
Neuropeptide Y – Its role in human performance and extreme environments
Camilla Kienast, Hanns-Christian Gunga, Mathias Steinach
REACH
Camilla Kienast, Hanns-Christian Gunga, Mathias Steinach
REACH
10.
The effect of leptin on blood pressure considering smoking status: a Mendelian randomization study
Luqi Shen, José Cordero, Jia-Sheng Wang, Ye Shen, Ruiyuan Zhang, Yanling Qi, Changwei Li
Hypertension Research
Luqi Shen, José Cordero, Jia-Sheng Wang, Ye Shen, Ruiyuan Zhang, Yanling Qi, Changwei Li
Hypertension Research
11.
Associations between Maternal and Fetal Levels of Total Adiponectin, High Molecular Weight Adiponectin, Selected Somatomedins, and Birth Weight of Infants of Smoking and Non-Smoking Mothers
Magdalena Chełchowska, Joanna Gajewska, Tomasz Maciejewski, Joanna Mazur, Mariusz Ołtarzewski, Jadwiga Ambroszkiewicz
International Journal of Environmental Research and Public Health
Magdalena Chełchowska, Joanna Gajewska, Tomasz Maciejewski, Joanna Mazur, Mariusz Ołtarzewski, Jadwiga Ambroszkiewicz
International Journal of Environmental Research and Public Health
12.
Nicotine-mediated upregulation of microRNA-141 expression determines adipokine-intervened insulin resistance
Amna Faheem, Kanwal Rehman, Komal Jabeen, Muhammad Akash
Environmental Toxicology and Pharmacology
Amna Faheem, Kanwal Rehman, Komal Jabeen, Muhammad Akash
Environmental Toxicology and Pharmacology
13.
Nicotine and energy balance: A review examining the effect of nicotine on hormonal appetite regulation and energy expenditure
Alexander Schwartz, Nick Bellissimo
Appetite
Alexander Schwartz, Nick Bellissimo
Appetite
14.
Cigarette smoking/cessation and metabolic syndrome
Genovefa Kolovou, Vana Kolovou, Sophie Mavrogeni
Clinical Lipidology
Genovefa Kolovou, Vana Kolovou, Sophie Mavrogeni
Clinical Lipidology
15.
Diabetogenic and Obesogenic Effects of Cadmium in Db/Db Mice and Rats at a Clinically Relevant Level of Exposure
Jessica Nguyen, Arjun Patel, Andrew Gensburg, Rehman Bokhari, Peter Lamar, Joshua Edwards
Toxics
Jessica Nguyen, Arjun Patel, Andrew Gensburg, Rehman Bokhari, Peter Lamar, Joshua Edwards
Toxics
16.
Second Trimester Maternal Leptin Levels Are Associated with Body Mass Index and Gestational Weight Gain but not Birth Weight of the Infant
Solveig Serapio, Fredrik Ahlsson, Anders Larsson, Theodora Kunovac Kallak
Hormone Research in Paediatrics
Solveig Serapio, Fredrik Ahlsson, Anders Larsson, Theodora Kunovac Kallak
Hormone Research in Paediatrics
17.
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Wali, Archana Burman
Journal of Cellular Biochemistry
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Wali, Archana Burman
Journal of Cellular Biochemistry
18.
The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus
Stamatina Driva, Aliki Korkontzelou, Serena Tonstad, Nikolaos Tentolouris, Paraskevi Katsaounou
International Journal of Environmental Research and Public Health
Stamatina Driva, Aliki Korkontzelou, Serena Tonstad, Nikolaos Tentolouris, Paraskevi Katsaounou
International Journal of Environmental Research and Public Health
19.
Estimation of Serum Leptin, Adiponectin, and Malondialdehyde Levels in Tobacco-Induced Oral Squamous Cell Carcinoma: ELISA-Based Study
Mala Kamboj, Gitika Sharma, Anjali Narwal, Paramjeet Gill, Anju Devi, Jagveer Yadav
South Asian Journal of Cancer
Mala Kamboj, Gitika Sharma, Anjali Narwal, Paramjeet Gill, Anju Devi, Jagveer Yadav
South Asian Journal of Cancer
20.
Paclobutrazol ameliorates cigarette smoke-induced chronic obstructive pulmonary disease (COPD) in experimental rats
Xuan Ma, Jinzhao Zhang, Shengyu Wang, Yaming Li, Aziz Abdel, Xin Diao
Arabian Journal of Chemistry
Xuan Ma, Jinzhao Zhang, Shengyu Wang, Yaming Li, Aziz Abdel, Xin Diao
Arabian Journal of Chemistry
21.
Adiponectin – stratification biomarker in diastolic cardiac dysfunction
Valeriu-Gabi Dincă, Adriana Diaconu, Bogdan-Ioan Coculescu, Alexandra-Ligia Dincă, Diana Mihaela Ciuc, Rodica Daniela Bîrlă, Cristian Daniel Marica, Sorin Ioan Tudorache, Gheorghe Manole, Elena Claudia Coculescu
Journal of Enzyme Inhibition and Medicinal Chemistry
Valeriu-Gabi Dincă, Adriana Diaconu, Bogdan-Ioan Coculescu, Alexandra-Ligia Dincă, Diana Mihaela Ciuc, Rodica Daniela Bîrlă, Cristian Daniel Marica, Sorin Ioan Tudorache, Gheorghe Manole, Elena Claudia Coculescu
Journal of Enzyme Inhibition and Medicinal Chemistry
22.
Association of serum leptin and ghrelin levels with smoking status on body weight: a systematic review and meta-analysis
Nour Shaheen, Ahmed Shaheen, Rehab Adel Diab, Abdelrahman M. Saad, Omar Ahmed Abdelwahab, Sama Soliman, Mahmoud Tarek Hefnawy, Alaa Ramadan, Mostafa Meshref, Abdulqadir J. Nashwan
Frontiers in Psychiatry
Nour Shaheen, Ahmed Shaheen, Rehab Adel Diab, Abdelrahman M. Saad, Omar Ahmed Abdelwahab, Sama Soliman, Mahmoud Tarek Hefnawy, Alaa Ramadan, Mostafa Meshref, Abdulqadir J. Nashwan
Frontiers in Psychiatry
23.
Longitudinal Analysis of Diabetes Mellitus Risk: Smoking Status and Smoking Cessation
Da-Eun Sung, Seung-Jae Lee, Mi-Yeon Lee, Eun-Jung Rhee, Ki-Chul Sung
Journal of Clinical Medicine
Da-Eun Sung, Seung-Jae Lee, Mi-Yeon Lee, Eun-Jung Rhee, Ki-Chul Sung
Journal of Clinical Medicine
24.
Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus
Stamatina Driva, Aliki Korkontzelou, Serena Tonstad, Nikolaos Tentolouris, Eleni Litsiou, Vasiliki Vasileiou, Alice G. Vassiliou, Vassiliki Saltagianni, Paraskevi Katsaounou
Biomedicines
Stamatina Driva, Aliki Korkontzelou, Serena Tonstad, Nikolaos Tentolouris, Eleni Litsiou, Vasiliki Vasileiou, Alice G. Vassiliou, Vassiliki Saltagianni, Paraskevi Katsaounou
Biomedicines
Share
RELATED ARTICLE
| eISSN: | 1617-9625 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
